July 2 (Reuters) - Windtree Therapeutics Inc WINT.O:
WINDTREE ANNOUNCES ISSUANCE OF ISTAROXIME PATENT FOR THE UNITED STATES FOR ACUTE HEART FAILURE
WINDTREE THERAPEUTICS INC - ISTAROXIME PATENT PROVIDES PROTECTION UNTIL 2039
WINDTREE THERAPEUTICS INC - ISTAROXIME APPROACHING PHASE 3 READINESS IN CARDIOGENIC SHOCK
Source text: ID:nGNX296ZyY
Further company coverage: WINT.O
((Reuters.Briefs@thomsonreuters.com;))